{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:39:51Z","timestamp":1783139991240,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Behav Health Serv Res"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11414-024-09878-3","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T21:35:36Z","timestamp":1710192936000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patterns of polydrug use among Black Americans who misuse opioids"],"prefix":"10.1007","volume":"52","author":[{"given":"Khary K.","family":"Rigg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan S.","family":"Kusiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"9878_CR1","doi-asserted-by":"publisher","unstructured":"Schuler MS, Schell TL, Wong EC. Racial\/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999\u20132018. Drug and Alcohol Dependence. 2021;221:108588. Available at: https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108588. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugalcdep.2021.108588"},{"key":"9878_CR2","doi-asserted-by":"publisher","unstructured":"Han B, Volkow ND, Compton WM, et al. Reported heroin use, use disorder, and injection among adults in the United States, 2002\u20132018. JAMA. 2020;323(6):568\u2013571. Available at: https:\/\/doi.org\/10.1001\/jama.2019.20844. Accessed 6 September, 2023.","DOI":"10.1001\/jama.2019.20844"},{"key":"9878_CR3","doi-asserted-by":"publisher","unstructured":"Rigg KK, Nicholson HL. Prescription opioid misuse among African-American adults: A rural-urban comparison of prevalence and risk. Drug and Alcohol Dependence. 2019;197:191\u2013196. Available at: https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.023. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugalcdep.2019.01.023"},{"key":"9878_CR4","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2022 National Survey on Drug Use and Health: Key substance use and mental health indicators in the United States. Center for Behavioral Health Statistics and Quality. Publication Number PEP23-07-01-006, 2023. Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42731\/2022-nsduh-nnr.pdf. Accessed 12 December, 2023."},{"key":"9878_CR5","doi-asserted-by":"publisher","unstructured":"Hsu DJ, McCarthy EP, Stevens JP, et al. Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001\u201312. Addiction. 2017;112(9):1558\u20131564. Available at: https:\/\/doi.org\/10.1111\/add.13795. Accessed 6 September, 2023.","DOI":"10.1111\/add.13795"},{"key":"9878_CR6","unstructured":"Joint Economic Committee. The economic toll of the opioid crisis reached nearly $1.5 trillion in 2020. September, 2022. Available at: https:\/\/www.jec.senate.gov\/public\/index.cfm\/democrats\/issue-briefs?ID=CE55E977-B473-414F-8B88-53EB55EB7C7C. Accessed 6 September, 2023."},{"key":"9878_CR7","doi-asserted-by":"publisher","unstructured":"Langabeer JR, Stotts AL, Bobrow BJ, et al. Prevalence and charges of opioid-related visits to US emergency departments. Drug and Alcohol Dependence. 2021;221:108568. Available at: https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108568. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugalcdep.2021.108568"},{"key":"9878_CR8","doi-asserted-by":"publisher","unstructured":"Rigg KK, Rigg MS. Opioid-induced hearing loss and neonatal abstinence syndrome: Clinical considerations for audiologists and recommendations for future research. American Journal of Audiology. 2020;29(4):701\u2013709. Available at: https:\/\/doi.org\/10.1044\/2020_AJA-20-00054. Accessed 6 September, 2023.","DOI":"10.1044\/2020_AJA-20-00054"},{"key":"9878_CR9","doi-asserted-by":"publisher","unstructured":"Chavez MN, Rigg KK. Nutritional implications of opioid use disorder: A guide for drug treatment providers. Psychology of Addictive Behaviors. 2020;34(6):699\u2013707. Available at: https:\/\/doi.org\/10.1037\/adb0000575. Accessed 6 September, 2023.","DOI":"10.1037\/adb0000575"},{"key":"9878_CR10","doi-asserted-by":"publisher","unstructured":"Szalavitz M, Rigg KK. The curious (dis) connection between the opioid epidemic and crime. Substance Use & Misuse. 2017;52(14):1927\u20131931. Available at: https:\/\/doi.org\/10.1080\/10826084.2017.1376685. Accessed 6 September, 2023.","DOI":"10.1080\/10826084.2017.1376685"},{"key":"9878_CR11","doi-asserted-by":"publisher","unstructured":"Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Prescription opioid misuse and mental health among young injection drug users. The American Journal of Drug and Alcohol Abuse. 2015;41(1):100\u2013106. Available at: https:\/\/doi.org\/10.3109\/00952990.2014.940424. Accessed 6 September, 2023.","DOI":"10.3109\/00952990.2014.940424"},{"key":"9878_CR12","doi-asserted-by":"publisher","unstructured":"Buttram ME, Kurtz SP, Surratt HL, et al. Health and social problems associated with prescription opioid misuse among a diverse sample of substance-using MSM. Substance Use & Misuse. 2014;49(3):277\u2013284. Available at: https:\/\/doi.org\/10.3109\/10826084.2013.828754. Accessed 6 September, 2023.","DOI":"10.3109\/10826084.2013.828754"},{"key":"9878_CR13","doi-asserted-by":"publisher","unstructured":"Rigg KK, DeCamp W. Explaining prescription opioid misuse among veterans: A theory-based analysis using structural equation modeling. Military Behavioral Health. 2014;2(2):210\u2013216. Available at: https:\/\/doi.org\/10.1080\/21635781.2014.917011. Accessed 6 September, 2023.","DOI":"10.1080\/21635781.2014.917011"},{"key":"9878_CR14","doi-asserted-by":"publisher","unstructured":"Surratt H, Kurtz SP, Cicero TJ. Alternate routes of administration and risk for HIV among prescription opioid abusers. Journal of Addictive Diseases. 2011;30(4):334\u2013341. Available at: https:\/\/doi.org\/10.1080\/10550887.2011.609805. Accessed 6 September, 2023.","DOI":"10.1080\/10550887.2011.609805"},{"key":"9878_CR15","doi-asserted-by":"crossref","unstructured":"Kariisa M, Davis NL, Kumar S, et al. Vital signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020. Morbidity and Mortality Weekly Report. 2022;71(29):940. Available at: 10.15585%2Fmmwr.mm7129e2. Accessed 6 September, 2023.","DOI":"10.15585\/mmwr.mm7129e2"},{"key":"9878_CR16","doi-asserted-by":"publisher","unstructured":"Glicksberg L, Dempsey SK, Casey BK. Heroin and fentanyl in Dallas County: A 5\u2010year retrospective review of toxicological, seized drug, and demographical data. Journal of Forensic Sciences. 2023;68(1):222\u2013232. Available at: https:\/\/doi.org\/10.1111\/1556-4029.15155. Accessed 6 September, 2023.","DOI":"10.1111\/1556-4029.15155"},{"key":"9878_CR17","doi-asserted-by":"publisher","unstructured":"Bunting AM, Oser C, Staton M, et al. Polysubstance use patterns among justice-involved individuals who use opioids. Substance Use & Misuse. 2020;55(13):2165\u20132174. Available at: https:\/\/doi.org\/10.1080\/10826084.2020.1795683. Accessed 6 September, 2023.","DOI":"10.1080\/10826084.2020.1795683"},{"key":"9878_CR18","doi-asserted-by":"publisher","unstructured":"Lim JK, Earlywine JJ, Bagley SM, et al. Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999\u20132018. JAMA pediatrics. 2021 Feb 1;175(2):194\u20136. Available at: https:\/\/doi.org\/10.1001\/jamapediatrics.2020.5035. Accessed 6 September, 2023.","DOI":"10.1001\/jamapediatrics.2020.5035"},{"key":"9878_CR19","unstructured":"Centers for Disease Control and Prevention. US overdose deaths in 2021 increased half as much as in 2020\u2014but are still up 15%. National Center for Health Statistics. 2022 May 11;16:2022. Available at: https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm. Accessed 6 September, 2023."},{"key":"9878_CR20","unstructured":"Goodnough A. Overdose deaths have surged during the pandemic, C.D.C. Data shows. New York, NY: The New York Times, 2021. Available at: https:\/\/www.nytimes.com\/2021\/04\/14\/health\/overdose-deaths-fentanyl-opiods-coronaviurs-pandemic.html. Accessed 6 September, 2023."},{"key":"9878_CR21","doi-asserted-by":"crossref","unstructured":"Boileau-Falardeau M, Contreras G, Garipy G, et al. Patterns and motivations of polysubstance use: A rapid review of the qualitative evidence. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice. 2022;42(2):47\u201359. Available at: 10.24095%2Fhpcdp.42.2.01. Accessed 6 September, 2023.","DOI":"10.24095\/hpcdp.42.2.01"},{"key":"9878_CR22","doi-asserted-by":"publisher","unstructured":"Moses T, Lundahl LH, Greenwald MK. Factors associated with sedative use and misuse among heroin users. Drug and Alcohol Dependence. 2018;185:10\u201316. Available at: https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.11.035. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugalcdep.2017.11.035"},{"key":"9878_CR23","unstructured":"Food and Drug Administration. FDA Drug Safety Communications, FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressant: Careful medication management can reduce risks. Food and Drug Administration, August, 2016. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or. Accessed 6 September, 2023."},{"key":"9878_CR24","unstructured":"Lamonica AK, Boeri M. An exploration of the relationship between the use of methamphetamine and prescription drugs. Journal of Ethnographic and Qualitative Research. 2012;6(3):160. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmc3532935\/. Accessed 6 September, 2023."},{"key":"9878_CR25","doi-asserted-by":"publisher","unstructured":"Rigg KK, Sharp A. Nonmedical prescription drug use among African Americans who use MDMA (ecstasy\/molly): Implications for risk reduction. Addictive Behaviors. 2018;79:159\u2013165. Available at: https:\/\/doi.org\/10.1016\/j.addbeh.2017.12.024. Accessed 6 September, 2023.","DOI":"10.1016\/j.addbeh.2017.12.024"},{"key":"9878_CR26","doi-asserted-by":"publisher","unstructured":"Lankenau SE, Teti M, Silva K, et al. Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health. 2012;89:1004\u20131016. Available at: https:\/\/doi.org\/10.1007\/s11524-012-9691-9. Accessed 6 September, 2023.","DOI":"10.1007\/s11524-012-9691-9"},{"key":"9878_CR27","doi-asserted-by":"publisher","unstructured":"Rigg KK, Iba\u00f1ez GE. Motivations for non-medical prescription drug use: A mixed methods analysis. Journal of Substance Abuse Treatment. 2010;39(3):236\u2013247. Available at: https:\/\/doi.org\/10.1016\/j.jsat.2010.06.004. Accessed 6 September, 2023.","DOI":"10.1016\/j.jsat.2010.06.004"},{"key":"9878_CR28","doi-asserted-by":"publisher","unstructured":"Goodwin RD, Moeller SJ, Zhu J, et al. The potential role of cocaine and heroin co-use in the opioid epidemic in the United States. Addictive Behaviors. 2021;113:106680. Available at: https:\/\/doi.org\/10.1016\/j.addbeh.2020.106680Accessed 6 September, 2023.","DOI":"10.1016\/j.addbeh.2020.106680"},{"key":"9878_CR29","doi-asserted-by":"publisher","unstructured":"Valente PK, Bazzi AR, Childs E, et al. Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the US Northeast. International Journal of Drug Policy. 2020;85:102934. Available at: https:\/\/doi.org\/10.1016\/j.drugpo.2020.102934. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugpo.2020.102934"},{"key":"9878_CR30","doi-asserted-by":"publisher","unstructured":"Rigg KK, Sharp A. Deaths related to MDMA (ecstasy\/molly): Prevalence, root causes, and harm reduction interventions. Journal of Substance Use. 2018;23(4):345\u2013352. Available at: https:\/\/doi.org\/10.1080\/14659891.2018.1436607. Accessed 6 September, 2023.","DOI":"10.1080\/14659891.2018.1436607"},{"key":"9878_CR31","doi-asserted-by":"publisher","unstructured":"Van Hout MC, Bingham T. \u201cA costly turn on\u201d: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy. 2012;23(3):188\u2013197. Available at: https:\/\/doi.org\/10.1016\/j.drugpo.2012.01.008. Accessed 6 September, 2023.","DOI":"10.1016\/j.drugpo.2012.01.008"},{"key":"9878_CR32","doi-asserted-by":"publisher","unstructured":"Cooper ZD, Bedi G, Ramesh D, et al. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology. 2018;43(10):2046\u20132055. Available at: https:\/\/doi.org\/10.1038\/s41386-018-0135-6. Accessed 6 September, 2023.","DOI":"10.1038\/s41386-018-0135-6"},{"key":"9878_CR33","doi-asserted-by":"publisher","unstructured":"Townsend T, Kline D, Rivera-Aguirre A, Bunting AM, Mauro PM, Marshall BD, Martins SS, Cerd\u00e1 M. Racial\/ethnic and geographic trends in combined stimulant\/opioid overdoses, 2007\u20132019. American Journal of Epidemiology. 2022;191(4):599\u2013612. Available at: https:\/\/doi.org\/10.1093\/aje\/kwab290. Accessed 25 November, 2023.","DOI":"10.1093\/aje\/kwab290"},{"key":"9878_CR34","doi-asserted-by":"publisher","unstructured":"Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379\u2013381. Available at: https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.0004. Accessed 6 September, 2023.","DOI":"10.1001\/jamapsychiatry.2022.0004"},{"key":"9878_CR35","doi-asserted-by":"publisher","unstructured":"Nicholson Jr HL. Socioeconomic status, fundamental cause theory, and prescription opioid use behaviors: a theoretical examination. Sociological Spectrum. 2020;40(1):1\u201332. Available at: https:\/\/doi.org\/10.1080\/02732173.2019.1707138. Accessed 25 November, 2023.","DOI":"10.1080\/02732173.2019.1707138"},{"key":"9878_CR36","unstructured":"Substance Abuse and Mental Health Services Administration. The opioid crisis and the Black\/African American population: An urgent issue. Center for Behavioral Health Statistics and Quality. Publication Number PEP20\u201305- 02\u2013001. 2020. Available at https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-05-02-001.pdf. Accessed 25 November, 2023."},{"key":"9878_CR37","doi-asserted-by":"publisher","unstructured":"Santoro TN, Santoro JD. Racial bias in the US opioid epidemic: A review of the history of systemic bias and implications for care. Cureus. 2018;10(12). Available at: https:\/\/doi.org\/10.7759\/cureus.3733. Accessed 25 November, 2023.","DOI":"10.7759\/cureus.3733"},{"key":"9878_CR38","doi-asserted-by":"publisher","unstructured":"Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the US opioid crisis. Molecular Psychiatry. 2021;26(1):41\u201350. Available at: https:\/\/doi.org\/10.1038\/s41380-020-00949-3. Accessed 6 September, 2023.","DOI":"10.1038\/s41380-020-00949-3"},{"key":"9878_CR39","doi-asserted-by":"publisher","unstructured":"Rigg KK, McLean K, Monnat SM, et al. Opioid misuse initiation: Implications for intervention. Journal of Addictive Diseases. 2018;37(3\u20134):111\u2013122. Available at: https:\/\/doi.org\/10.1080\/10550887.2019.1609336. Accessed 6 September, 2023.","DOI":"10.1080\/10550887.2019.1609336"},{"key":"9878_CR40","unstructured":"Creswell JW. A concise introduction to mixed methods research. SAGE publications, 2021. Available at: https:\/\/books.google.com\/books?id=xLU6EAAAQBAJ&printsec=frontcover&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false. Accessed 6 September, 2023"},{"key":"9878_CR41","unstructured":"Substance Abuse and Mental Health Services Administration. 2014 National survey on drug use and health: Methodological summary and definitions. Center for Behavioral Health Statistics and Quality. 2015. Available at: https:\/\/www.samhsa.gov\/data\/report\/2014-national-survey-drug-use-and-health-methodological-summary-and-definitions. Accessed 6 September, 2023."},{"key":"9878_CR42","unstructured":"Substance Abuse and Mental Health Services Administration. Reliability of key measures in the national survey on drug use and health. Office of Applied Studies. Publication Number SMA 09-4425, 2014. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/2k6ReliabilityP\/2k6ReliabilityP.pdf. Accessed 6 September, 2023."},{"key":"9878_CR43","doi-asserted-by":"publisher","unstructured":"Hilal AH, Alabri SS. Using NVivo for data analysis in qualitative research. International Interdisciplinary Journal of Education. 2013 Jan;2(2):181\u2013186. Accessed at: https:\/\/doi.org\/10.13140\/RG.2.2.20913.10082. Accessed 6 September, 2023.","DOI":"10.13140\/RG.2.2.20913.10082"},{"key":"9878_CR44","doi-asserted-by":"publisher","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006 Jan 1;3(2):77\u2013101. Available at: https:\/\/doi.org\/10.1191\/1478088706qp063oa. Accessed 6 September, 2023.","DOI":"10.1191\/1478088706qp063oa"},{"key":"9878_CR45","unstructured":"Clarke V, Braun V, Hayfield N. Thematic analysis. Qualitative psychology: A practical guide to research methods. 2015 Jan 1;3:222\u201348. Available at: http:\/\/digital.casalini.it\/9781473933415. Accessed 6 September, 2023."},{"key":"9878_CR46","doi-asserted-by":"publisher","unstructured":"Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. The Qualitative Report. 2015;20(9):1408\u20131416. Available at: https:\/\/doi.org\/10.46743\/2160-3715\/2015.2281. Accessed 25 November, 2023.","DOI":"10.46743\/2160-3715\/2015.2281"},{"key":"9878_CR47","doi-asserted-by":"publisher","unstructured":"Ahmed S, Sarfraz Z, Sarfraz A. A changing epidemic and the rise of opioid-stimulant co-use. Frontiers in Psychiatry. 2022;13:918197. Available at: https:\/\/doi.org\/10.3389\/fpsyt.2022.918197. Accessed 25 November, 2023.","DOI":"10.3389\/fpsyt.2022.918197"},{"key":"9878_CR48","doi-asserted-by":"publisher","unstructured":"Rigg KK, Menendez KM. Drug prevention programmes in schools: Selecting programme providers.\u00a0Health Education Journal. 2018;77(5):586\u2013597. Available at: https:\/\/doi.org\/10.1177\/0017896918763454. Accessed 9 February, 2024.","DOI":"10.1177\/0017896918763454"},{"key":"9878_CR49","doi-asserted-by":"publisher","unstructured":"Silva K, Kecojevic A, Lankenau SE. Perceived drug use functions and risk reduction practices among high-risk nonmedical users of prescription drugs. Journal of Drug Issues. 2013;43(4):483\u2013496. Available at: https:\/\/doi.org\/10.1177\/0022042613491099. Accessed 6 September, 2023.","DOI":"10.1177\/0022042613491099"},{"key":"9878_CR50","doi-asserted-by":"publisher","unstructured":"Chastain G. Alcohol, neurotransmitter systems, and behavior. The Journal of General Psychology. 2006;133(4):329\u2013335. Available at: https:\/\/doi.org\/10.3200\/GENP.133.4.329-335. Accessed 6 September, 2023.","DOI":"10.3200\/GENP.133.4.329-335"},{"key":"9878_CR51","doi-asserted-by":"publisher","unstructured":"Laqueille X, Launay C, Dervaux A, et al. Abus d'alcool et de benzodiaz\u00e9pines lors des traitements de substitution chez l'h\u00e9ro\u00efnomane : Une revue de la litt\u00e9rature [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: A review of the literature]. L'Enc\u00e9phale. 2009 Jun 1;35(3):220\u20135. Available at: https:\/\/doi.org\/10.1016\/j.encep.2008.05.005. Accessed 6 September, 2023","DOI":"10.1016\/j.encep.2008.05.005"},{"key":"9878_CR52","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Alcohol\u2019s effects on health: Research-based information on drinking and its impact. National Institute of Health. 2014. Available at: https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohols-effects-body. Accessed 6 September, 2023."},{"key":"9878_CR53","doi-asserted-by":"publisher","unstructured":"White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999 Jul;94(7):961\u201372. Available at: https:\/\/doi.org\/10.1046\/j.1360-0443.1999.9479612.x. Accessed 6 September, 2023.","DOI":"10.1046\/j.1360-0443.1999.9479612.x"},{"key":"9878_CR54","doi-asserted-by":"publisher","unstructured":"Ondocsin J, Holm N, Mars SG, et al. The motives and methods of methamphetamine and \u2018heroin\u2019 co-use in West Virginia. Harm Reduction Journal. 2023;20(1):1\u20139. Available at: https:\/\/doi.org\/10.1186\/s12954-023-00816-8. Accessed 6 September, 2023.","DOI":"10.1186\/s12954-023-00816-8"},{"key":"9878_CR55","doi-asserted-by":"publisher","unstructured":"Oliveira LG, Ponce JDC, Nappo SA. Crack cocaine use in Barcelona: A reason of worry. Substance Use & Misuse. 2010;45(13):2291\u20132300. Available at: https:\/\/doi.org\/10.3109\/10826081003682883. Accessed 6 September, 2023.","DOI":"10.3109\/10826081003682883"},{"key":"9878_CR56","doi-asserted-by":"publisher","unstructured":"Leri F, Bruneau J, Stewart J. Understanding polydrug use: Review of heroin and cocaine co\u2010use. Addiction. 2003;98(1):7\u201322. Available at: https:\/\/doi.org\/10.1046\/j.1360-0443.2003.00236.x. Accessed 6 September, 2023.","DOI":"10.1046\/j.1360-0443.2003.00236.x"},{"key":"9878_CR57","doi-asserted-by":"publisher","unstructured":"Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Medical Principles and Practice. 2018;27(5):401\u2013414. Available at: https:\/\/doi.org\/10.1159\/000492616. Accessed 6 September, 2023.","DOI":"10.1159\/000492616"},{"key":"9878_CR58","doi-asserted-by":"publisher","unstructured":"Hoffman RS. Treatment of patients with cocaine\u2010induced arrhythmias: Bringing the bench to the bedside. British Journal of Clinical Pharmacology. 2010 May;69(5):448\u2013457. Available at: https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03632.x. Accessed 6 September, 2023.","DOI":"10.1111\/j.1365-2125.2010.03632.x"},{"key":"9878_CR59","doi-asserted-by":"crossref","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry. 2021;34(4):344. Available at: 10.1097%2FYCO.0000000000000717. Accessed 25 November, 2023.","DOI":"10.1097\/YCO.0000000000000717"},{"key":"9878_CR60","doi-asserted-by":"publisher","unstructured":"Wang L, Min JE, Krebs E, et al. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. International Journal of Drug Policy. 2017;49:32\u201340. Available at: https:\/\/doi.org\/10.1016\/j.drugpo.2017.07.009. Accessed 25 November, 2023.","DOI":"10.1016\/j.drugpo.2017.07.009"},{"key":"9878_CR61","doi-asserted-by":"publisher","unstructured":"Bovasso G, Cacciola J. The long-term outcomes of drug use by methadone maintenance patients. The Journal of Behavioral Health Services & Research. 2003;30:290\u2013303. Available at: https:\/\/doi.org\/10.1007\/BF02287318. Accessed 25 November, 2023.","DOI":"10.1007\/BF02287318"},{"key":"9878_CR62","doi-asserted-by":"publisher","unstructured":"Demaria PA, Sterling R, Weinstein SP. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions. 2000;9(2):145\u201353. Available at: https:\/\/doi.org\/10.1080\/10550490050173217. Accessed 25 November, 2023.","DOI":"10.1080\/10550490050173217"},{"key":"9878_CR63","doi-asserted-by":"publisher","unstructured":"Baumeister M, Vogel M, D\u00fcrsteler-MacFarland KM, et al. Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: A register-based study. Substance Abuse Treatment, Prevention, and Policy. 2014;9(1):1\u20138. Available at: https:\/\/doi.org\/10.1186\/1747-597X-9-46. Accessed 25 November, 2023.","DOI":"10.1186\/1747-597X-9-46"},{"key":"9878_CR64","doi-asserted-by":"publisher","unstructured":"Peles E, Kreek MJ, Kellogg S, et al. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. Journal of Addictive Diseases. 2006;25(1):43\u201350. Available at: https:\/\/doi.org\/10.1300\/J069v25n01_07. Accessed 25 November, 2023.","DOI":"10.1300\/J069v25n01_07"},{"key":"9878_CR65","doi-asserted-by":"publisher","unstructured":"Szalavitz M, Rigg KK, Wakeman SE. Drug dependence is not addiction\u2014and it matters. Annals of Medicine. 2021 Jan 1;53(1):1989\u201392. Available at: https:\/\/doi.org\/10.1080\/07853890.2021.1995623. Accessed 9 February, 2024.","DOI":"10.1080\/07853890.2021.1995623"},{"key":"9878_CR66","doi-asserted-by":"publisher","unstructured":"McCabe SE, Cranford JA, Morales M, et al. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol. 2006;67(4):529\u201337. Available at: https:\/\/doi.org\/10.15288\/jsa.2006.67.529. Accessed 25 November, 2023.","DOI":"10.15288\/jsa.2006.67.529"},{"key":"9878_CR67","unstructured":"Bamsey, R. Polydrug use: Prevalence, predictors, pharmacology and psychopharmacology.\u00a0Yale Review of Undergraduate Research in Psychology,\u00a02017;7:20\u201347. Available at: https:\/\/www.researchgate.net\/publication\/318967256_Polydrug_Use_Prevalence_Predictors_Pharmacology_and_Psychopharmacology. Accessed 25 November, 2023."},{"key":"9878_CR68","doi-asserted-by":"publisher","unstructured":"Smit F, Monshouwer K, Verdurmen J. Polydrug use among secondary school students: Combinations, prevalences and risk profiles. Drugs: Education, Prevention and Policy. 2002;9(4):355\u201365. Available at: https:\/\/doi.org\/10.1080\/09687630210155313. Accessed 25 November, 2023.","DOI":"10.1080\/09687630210155313"},{"key":"9878_CR69","doi-asserted-by":"publisher","unstructured":"Karjalainen K, Kuussaari K, Kataja K, et al. Measuring concurrent polydrug use in general populations: A critical assessment. European Addiction Research. 2017 Jul 7;23(3):163\u20139. Available at: https:\/\/doi.org\/10.1159\/000477802. Accessed 25 November, 2023.","DOI":"10.1159\/000477802"},{"key":"9878_CR70","doi-asserted-by":"publisher","unstructured":"Silveira ML, Green VR, Iannaccone R, et al. Patterns and correlates of polysubstance use among US youth aged 15\u201317 years: Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Addiction. 2019;114(5):907\u201316. Available at: https:\/\/doi.org\/10.1111\/add.14547. Accessed 25 November, 2023.","DOI":"10.1111\/add.14547"}],"container-title":["The Journal of Behavioral Health Services & Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-024-09878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11414-024-09878-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-024-09878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:11:56Z","timestamp":1744643516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11414-024-09878-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9878"],"URL":"https:\/\/doi.org\/10.1007\/s11414-024-09878-3","relation":{},"ISSN":["1094-3412","1556-3308"],"issn-type":[{"value":"1094-3412","type":"print"},{"value":"1556-3308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"22 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}